Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marieke Arts-de Jong"'
Autor:
Inge van Dijk, Maria H. C. T. van Beek, Marieke Arts-de Jong, Peter L. B. J. Lucassen, Chris van Weel, Anne E. M. Speckens
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
PurposeTo explore the mindfulness practice, its long-term effects, facilitators and barriers, in clinical clerkship students 2 years after participation in an 8-week mindfulness-based stress reduction (MBSR) training.MethodA qualitative study was per
Externí odkaz:
https://doaj.org/article/6ca888b1c9e04704b7c2d539fed6c865
Autor:
Marieke Arts-de Jong, Cor A. J. DeJong, Rosella P. Hermens, David W. Kissane, Leon M. Massuger, Nicoline Hoogerbrugge, Judith B. Prins, Joanne A. deHullu
Publikováno v:
Journal of Psychosomatic Obstetrics and Gynecology, Vol 39, Iss 2, Pp 96-104 (2018)
Introduction: Demoralization is a relatively neglected issue in which low morale and poor coping result from a stressor such as familial cancer risk. Female BRCA1/2 mutation carriers are highly susceptible for developing breast and ovarian cancer. Th
Externí odkaz:
https://doaj.org/article/1439f6f2dd514eb489f6a423c2a06d92
Autor:
Angela H.E.M. Maas, Maria T. E. Hopman, Miranda P. Steenbeek, Michiel L. Bots, Nicoline Hoogerbrugge, Majke H.D. van Bommel, Liselore L.M. van Westerop, Marieke Arts de Jong, Joanne A. de Hullu
Publikováno v:
Journal of Cardiology, 77, 570-575
Journal of Cardiology, 77, 6, pp. 570-575
Journal of Cardiology, 77, 6, pp. 570-575
Background BRCA1/2 mutation carriers are generally exposed to early menopause due to risk-reducing salpingo-oophorectomy (RRSO) around the age of 40 years. This risk-reducing intervention is based on a 10–40% life-time risk of ovarian cancer in thi
Autor:
Monique M A Brood-van Zanten, M. Caroline Vos, Nicoline Hoogerbrugge, Majke H.D. van Bommel, Brigitte F. M. Slangen, Miranda P. Steenbeek, Rosella P.M.G. Hermens, Helena C. van Doorn, Marline G. Harmsen, Mirjam J.A. Apperloo, Leon F.A.G. Massuger, Marieke Arts de Jong, Steven Teerenstra, Marian J.E. Mourits, Ronald P. Zweemer, Johan Bulten, Jurgen M.J. Piek, Sjors F.P.J. Coppus, Marc van Beurden, Katja N. Gaarenstroom, Judith B. Prins, Joanna IntHout, Luc R.C.W. van Lonkhuijzen, Joanne A. de Hullu, Angela H.E.M. Maas
Publikováno v:
Steenbeek, M P, Harmsen, M G, Hoogerbrugge, N, de Jong, M A, Maas, A H E M, Prins, J B, Bulten, J, Teerenstra, S, van Bommel, M H D, van Doorn, H C, Mourits, M J E, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Slangen, B F M, Brood-van Zanten, M M A, Vos, M C, Piek, J M J, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, Massuger, L F A G, IntHout, J, Hermens, R P M G & de Hullu, J A 2021, ' Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers : A Nonrandomized Controlled Trial ', JAMA Oncology, vol. 7, no. 8, pp. 1203-1212 . https://doi.org/10.1001/jamaoncol.2021.1590
JAMA Oncology, 7(8), 1203-1212. American Medical Association
JAMA Oncol
JAMA oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
Jama Oncology, 7, 8, pp. 1203-1212
Jama Oncology, 7, 1203-1212
JAMA Oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
JAMA oncology, 7(8):653331861, 1203-1212. American Medical Association
JAMA Oncology, 7(8), 1203-1212. American Medical Association
JAMA Oncol
JAMA oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
Jama Oncology, 7, 8, pp. 1203-1212
Jama Oncology, 7, 1203-1212
JAMA Oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
JAMA oncology, 7(8):653331861, 1203-1212. American Medical Association
Item does not contain fulltext IMPORTANCE: Most women with a BRCA1/2 pathogenic variant undergo premature menopause with potential short- and long-term morbidity due to the current method of ovarian carcinoma prevention: risk-reducing salpingo-oophor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd3ab6a57c66f8094cd4c46b7ea1c46
https://research.vumc.nl/en/publications/18584e54-1f67-47ac-b63f-6a0cff8e02d3
https://research.vumc.nl/en/publications/18584e54-1f67-47ac-b63f-6a0cff8e02d3
Autor:
Judith B. Prins, Joanne A deHullu, Nicoline Hoogerbrugge, Cor A J DeJong, Rosella P.M.G. Hermens, David W. Kissane, Leon M Massuger, Marieke Arts-de Jong
Publikováno v:
Journal of Psychosomatic Obstetrics and Gynaecology, 39, 2, pp. 96-104
Journal of Psychosomatic Obstetrics and Gynaecology, 39, 96-104
Journal of Psychosomatic Obstetrics and Gynaecology, 39, 96-104
Contains fulltext : 190195.pdf (Publisher’s version ) (Open Access) Introduction: Demoralization is a relatively neglected issue in which low morale and poor coping result from a stressor such as familial cancer risk. Female BRCA1/2 mutation carrie
Autor:
Joanne A. de Hullu, C. Marleen Kets, Geertruida H. de Bock, Marieke Arts-de Jong, Christi J. van Asperen, Marian J.E. Mourits
Publikováno v:
European Journal of Cancer, 61, pp. 137-45
European Journal of Cancer, 61, 137-45
European Journal of Cancer, 61, 137-145
European Journal of Cancer, 61, 137-45
European Journal of Cancer, 61, 137-145
The presence of a germline BRCA1/2 mutation improves options for tailored risk-reducing strategies and treatment in both breast and ovarian cancer patients and their relatives. Currently, referral for germline BRCA1/2 mutation testing of women with e
Autor:
Liselore L.M. van Westerop, Marieke Arts-de Jong, Nicoline Hoogerbrugge, Angela H.E.M. Maas, Maria H. C. T. Van Beek, Joanne A. de Hullu, Leon F.A.G. Massuger
Publikováno v:
Maturitas, 108, pp. 13-17
Maturitas, 108, 13-17
Maturitas, 108, 13-17
Objectives To reduce the risk of ovarian cancer, BRCA1/2 mutation carriers are advised to undergo salpingo-oophorectomy (RRSO) around the age of 40 years. This may induce severe climacteric symptoms, potentially lowering their quality of life. Person
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1576134aff2b4c82c6f1ed2712a9f70
https://hdl.handle.net/2066/184046
https://hdl.handle.net/2066/184046
Autor:
Nicoline Hoogerbrugge, Marline G. Harmsen, Joanne A. de Hullu, Leon F.A.G. Massuger, Marieke Arts-de Jong, Rosella P.M.G. Hermens
Publikováno v:
Gynecologic Oncology, 136, 2, pp. 305-10
Gynecologic Oncology, 136, 305-10
Gynecologic Oncology, 136, 305-10
Contains fulltext : 153902.pdf (Publisher’s version ) (Closed access) OBJECTIVE: To identify influencing factors of BRCA1/2 mutation carriers and their professionals for risk-reducing salpingectomy (RRS) with delayed oophorectomy (RRO) as a substit